Approximately 10-13% of patients with Ewing sarcoma have germline mutation findings, with a large concentration in genes that regulate DNA damage repair. DNA damage repair pathways often cross-talk with pathways regulating inflammation. We have a number of exciting projects aimed at understanding how pathogenic germline variants in DNA damage repair genes may alter inflammatory signaling in Ewing tumors.